Nune, A.; Durkowski, V.; Pillay, S.S.; Barman, B.; Elwell, H.; Bora, K.; Bilgrami, S.; Mahmood, S.; Babajan, N.; Venkatachalam, S.;
et al. New-Onset Rheumatic Immune-Mediated Inflammatory Diseases Following SARS-CoV-2 Vaccinations until May 2023: A Systematic Review. Vaccines 2023, 11, 1571.
https://doi.org/10.3390/vaccines11101571
AMA Style
Nune A, Durkowski V, Pillay SS, Barman B, Elwell H, Bora K, Bilgrami S, Mahmood S, Babajan N, Venkatachalam S,
et al. New-Onset Rheumatic Immune-Mediated Inflammatory Diseases Following SARS-CoV-2 Vaccinations until May 2023: A Systematic Review. Vaccines. 2023; 11(10):1571.
https://doi.org/10.3390/vaccines11101571
Chicago/Turabian Style
Nune, Arvind, Victor Durkowski, S. Sujitha Pillay, Bhupen Barman, Helen Elwell, Kaustubh Bora, Syed Bilgrami, Sajid Mahmood, Nasarulla Babajan, Srinivasan Venkatachalam,
and et al. 2023. "New-Onset Rheumatic Immune-Mediated Inflammatory Diseases Following SARS-CoV-2 Vaccinations until May 2023: A Systematic Review" Vaccines 11, no. 10: 1571.
https://doi.org/10.3390/vaccines11101571
APA Style
Nune, A., Durkowski, V., Pillay, S. S., Barman, B., Elwell, H., Bora, K., Bilgrami, S., Mahmood, S., Babajan, N., Venkatachalam, S., Ottewell, L., & Manzo, C.
(2023). New-Onset Rheumatic Immune-Mediated Inflammatory Diseases Following SARS-CoV-2 Vaccinations until May 2023: A Systematic Review. Vaccines, 11(10), 1571.
https://doi.org/10.3390/vaccines11101571